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Abstract
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Hematopoietic stem cells (HSCs) preserve their ability to self-renew and differentiate to different
lineages in the bone marrow (BM) niche, which is composed in large part by BM stromal cells.
Studies have shown that altered signaling in the BM niche results in leukemia initiation or
progression. Fanconi anemia (FA) is an inherited BM failure syndrome associated with extremely
high risk of leukemic transformation. By employing two FA mouse models, here we have
investigated the hematopoiesis-supportive function of FA BM mesenchymal stroma cells (MSCs).
We found that MSCs deficient for Fanca or Fancc gene are defective in proliferation and prone to
undergo senescence in vitro. Mechanistically, we show that the activity of cell division control
protein 42 (Cdc42), a Rho GTPase known to be a critical regulator for cytoskeleton organization,
is significantly reduced in FA MSCs. Furthermore, we demonstrate that this reduction in Cdc42
activity plays a causal role in defective hematopoiesis-supportive function of the FA MSCs. The
progenies of WT HSPCs co-cultured on FA MSCs exhibit compromised self-renewal capacity
both in vitro and in vivo. Genetic correction of FA deficiency restores Cdc42 activity and improves
hematopoiesis-supportive capacity of FA MSC. Finally, ectopic expression of a constitutively
active Cdc42 mutant, Cdc42F28L, or pretreatment with Wnt5a, increases the active Cdc42 level
and rescues the hematopoietic supportive defects of FA MSCs. Taken together, our results identify
a novel link between Cdc42 activity and hematopoiesis-supportive function of MSCs and suggest
that a niche-specific increase of Cdc42 activity may be beneficial for FA therapy.
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Introduction
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Fanconi anemia (FA) is a rare inherited disease resulted from dysfunctional hematopoietic
stem cells [1, 2]. FA is genetically heterogeneous with at least 22 genes (FANCA-W)
identified thus far [1–11]. Patients with mutations in any of these genes lead to an FA
phenotype manifested by the cellular and phenotypic consequences of genetic instability,
growth retardation, congenital malformations, bone marrow (BM) failure, high risk of
neoplasia and premature aging [1, 2, 8]. The hematologic complications of FA are nearly
universal among patients with FA. In fact, progressive BM failure represents the major
causes of morbidity and mortality of FA. To date, allogenic hematopoietic stem cell
transplantation (HSCT) from related and unrelated donors is the only known definite therapy
for severe BM failure in patients with FA [1, 2].

Author Manuscript

The BM microenvironment provides unique regions that support the function of
hematopoietic stem cells (HSCs) and other hematopoietic lineages, including monocytes and
lymphocytes [12, 13]. Cells within these regions constitute the hematopoietic stem cell
(HSC) niche, which contributes to the control of HSC quiescence, proliferation, self-renewal
and differentiation [12, 13]. Recent studies have revealed that disordered niche function
could contribute to disease. For example, altered signaling in the BM stroma/niche results in
leukemia initiation or progression [14–16]. Conversely, leukemic cells can reprogram the
BM niche, which favors leukemic proliferation while compromising normal hematopoiesis
[17]. To date, only a few studies have described the functional characteristics of FA BM
mesenchymal stroma cells (MSCs) [18–20], all of which implicate a role of FA BM niche in
the pathophysiology of FA BM failure. Defining the role of BM niche in FA may reveal
potential therapies not only for FA but also for patients with BM failure and leukemia in
general.
Cell division control protein 42 (Cdc42) belongs to the Rho GTPase family, acting as an
intracellular signal transducer in response to a variety of extracellular stimuli [21, 22]. It can
Stem Cells. Author manuscript; available in PMC 2019 May 01.
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integrate signals from multiple cell surface receptors, such as c-kit, CXCR4, and β1-integrin,
to regulate cytoskeleton dynamics that impacts on cell adhesion and migration. These cell
functions are directly relevant to the retention of HSCs in the BM niche. Recent studies of a
conditional Cdc42 knockout mouse model and a Cdc42 gain-of activity, Cdc42GAP
knockout mouse model demonstrated that Cdc42 is uniquely required for HSC retention and
maintenance in the BM niche [23, 24]. Previous study indicated that the cell-autonomous
defect of FA HSCs in BM homing and engraftment is associated with a reduction in the
activity of Cdc42 [25]. In this study, we employed two FA mouse models to show that MSCs
isolated from Fanca−/− and Fancc−/− mice have low Cdc42 activity, which is correlated with
compromised hematopoiesis-supportive function. Genetic correction of FA deficiency or
activation of Cdc42 improves the capacity of FA MSCs to support hematopoiesis.

Materials and methods
Author Manuscript

Mice and treatment

Fanca+/+, Fanca−/− and Fancc+/+, Fancc−/− mice were generated by interbreeding the
heterozygous Fanca+/− or Fancc+/− mice [26, 27], respectively. 6–8 week-old BoyJ mice
were used as bone marrow transplant (BMT) recipients. Animals including BoyJ recipient
mice were maintained in the animal barrier facility at West Virginia University (WVU). All
experimental procedures conducted in this study were approved by the Institutional Animal
Care and Use Committee of WVU.
Mesenchymal stromal cell (MSC) culture and treatment

Author Manuscript

Whole bone marrow cells (WBMCs) were isolated from wild-type (WT), Fanca−/− and
Fancc−/− mice by gently flushing out of tibias and femurs using DPBS + 10% FBS. Cells
obtained from two tibias and two femurs were pooled and plated in 100mm culture dish (BD
Falcon, Tewksbury, MA) in 10 ml of MSCs media (Dulbecco’s Modified Eagle Medium
(DMEM, Gibco, Gaithersburg, MD) supplemented with 15% fetal bovine serum (FBS,
Gibco, Gaithersburg, MD) and 1% Penicillin-Streptomycin (Life Technologies # 15140-122
adapted and modified from previous report [27].
Plastic adherent cells were passaged 3 times followed by staining with fluorescently labelled
antibodies for mesenchymal (CD29, CD44, CD73, SCA-1, CD106) and hematopoietic
markers (CD45, CD11b) using the mouse multipotent mesenchymal stromal cell marker
antibody panel (Cat # SC018; R&D systems; Minneapolis, MN) [28–30]. We confirmed that
at least 98% purity of MSCs was obtained with this culture method.
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For Wnt5a treatment, MSCs at passages three were plated to obtain 95% confluence. Cells
were pre-treated with different doses of Wnt5a (R&D System, Minneapolis, MN) for 16 hrs
[31], followed by co-culture in fresh media with WT LSK (Lin−Sca1+c-kit+) cells.
Senescence-associated-β-galactosidase activity analysis
Senescence-associated-β-galactosidase (SA-β-gal) activity was determined using an SA-βgal staining kit from Cell Signaling Technology (Beverly, MA) in accordance to the
manufacturer’s instruction. Briefly, cells were washed in phosphate-buffered saline (PBS)
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and fixed in 2% formaldehyde-0.2% glutaraldehyde. Then the cells were washed and
incubated at 37°C incubator overnight with fresh SA-β-gal stain solution [1 mg/ml 5bromo-4-chloro-3-indolyl-β-D-galactopyranoside, 40 mM citric acid-sodium phosphate (pH
6.0), 150 mM NaCl, 2 mM MgCl2, and 5 mM potassium ferricyanide]. Senescent cells were
identified as blue-stained cells by standard light microscopy, and a total of 500 cells were
counted in random fields to determine the percentage of SA-β-gal-positive cells.
MSC colony forming efficiency (CFE)

Author Manuscript

MSC CFE assay was performed following the manufacturer’s instruction (CELLnTEC,
Ontario, Canada). Briefly, 100 MSCs were seeded into 100 mm diameter dish in 10 ml of
MSC medium. Cells were grown for 12 days at 37 °C without further medium changes.
After 12 days, culture media were removed. Cells were rinsed with PBS then fixed using
100% MeOH for 5 min at room temperature. Cells were then stained with Stain Solution I
and II subsequently. Colonies were visualized and enumerated under microscopy.
Cell adhesion assay
Cell-cell adhesion was performed by adding sorted LSK cells from WT mice onto confluent
WT, Fanca−/− or Fancc−/− BM-derived MSCs and incubated at 37°C for 4 hours. Nonadherent cells were then subjected to colony forming cell (CFC) assay. Progenitor adhesion
was shown as a percentage of the input CFCs.
Western blot and Cdc42-GTPase effector domain pull-down assays
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Relative levels of GTP-bound Cdc42 were determined by an effector pull-down assay [25].
Briefly, 1×106 of lineage-depleted bone-marrow cells were lysed in a Mg2+ lysis/wash buffer
(Upstate cell signaling solutions, Boston, MA) containing 10% glycerol, 25 mM sodium
fluoride, 1 mM sodium orthovanadate and a protease inhibitor cocktail (Roche Diagnostics,
Indianapolis, IN). Samples were incubated with PAK-1 binding domain/agarose beads and
bound (activated) as well as unbound (non-activated) Cdc42 fractions were probed by
immunoblotting with antibody against Cdc42 (rabbit polyclonal, Millipore, Billerica, MA).
Activated protein was normalized to total protein and/or β-actin (Sigma-Aldrich, St. Louis,
MO) and the relative amount was quantified using ImageJ software (NIH). To detect Wnt5a
protein levels, cells were lysed as described above and directly blotted with a goat antimouse Wnt5a antibody (R&D Systems, Minneapolis, MN). Wnt5a protein levels were
normalized based on actin protein levels in the same blotted samples.
Cobble stone Area Forming Cell assay (CAFC)

Author Manuscript

WT bone marrow cells (BMCs) were seeded on top of confluent WT, Fanca−/− and Fancc−/−
MSCs in 35 mm culture dish (BD Falcon, Tewksbury, MA) and allow the precursor cells
forming hematopoietic clones under the stromal layers [19, 32]. The cells were cocultured in
37°C incubator supplemented with 5% CO2 and fed weekly by half medium change. Phasedark hematopoietic clone was imaged under phase contrast images were taken at 20×
objective. The identified area was analyzed with ImageJ software (NIH).
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Limited dilution assay (LDA)
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Limited dilution assay (LDA) of a LSK cells was conducted by the use of five dilutions (0,
10, 20, 90, 270, and 810) differing with a factor of 3 and 10 wells per cell concentration
[19]. Three different LDA experiments were performed with independently derived MSCs
from WT, Fanca−/− and Fancc−/− mice. A well was scored as “positive” if contained one or
more cobblestone areas and “negative” if contained no cobblestone areas. Cobblestone area
is at least 6 cells (in proximity of each other) growing underneath the stroma. Although
cobblestone-like cells appear as phase dark, these cells appear as nonregractile in 96-well
plates because of the deflection of light. Only dilution with both negative and positive wells
are informative for frequent analysis.
Bone marrow transplantation (BMT)

Author Manuscript

In the competitive repopulation study, 1×105 output cells (CD45.2+) collected from cocultures were mixed with 3×105 competitor cells (CD45.1+), and injected into lethally
irradiated (split dose of 700 Rad + 475 Rad with 3 hours apart) BoyJ mice (CD45.1+). After
16 weeks, the recipient mice were sacrificed, and nucleated cells from peripheral blood and
the BM were analyzed were stained with CD45.2 and CD45.1 for donor-derived chimeras.
For secondary BMT, 3 million of WBMCs from primary recipients were pooled and injected
into sublethally irradiated (7.0 Gy) BoyJ recipients.
Molecular cloning and materials

Author Manuscript

For retroviral vector construction, full-length FANCA or FANCC cDNA were cloned into
MIEG3-GFP vector [25, 33]. The Cdc42(F28L) cDNA, a Cdc42 mutant that constitutively
exchanges GDP for GTP but still hydrolyzes GTP [33], was subcloned into the BamH1 and
EcoR1 sites of the MIEG3 retroviral vector. The plasmids (10 µg each) were used to produce
retroviral supernatant.
RNA Isolation, Reverse Transcriptase (RT)-PCR
Total RNA isolated from cells of the indicated genotypes was prepared by using RNeasy kit
(Qiagen, Valencia, CA) following the manufacturer’s procedure. Reverse transcription was
performed with random hexamers and Superscript II RT (Invitrogen, Grand Island, NY) and
was carried out at 42 °C for 60 min and stopped at 95 °C for 5 min. First-strand cDNA was
used for real-time PCR using primers listed in Table S1. Samples were normalized to the
level of GAPDH mRNA.
Determination of Wnt5a protein level
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Protein levels of Wnt5a in WT, Fanca−/− or Fancc−/− MSCs were measured by ELISA assay
following manufacturer’s instruction (Cloud-Clone Corp., TX, USA).
Statistical analysis
Paired or unpaired student’s t-test was used for two-group comparisons. Survival data were
plotted by the Kaplan-Meier curve method and analyzed by the log-rank test. Values of
p<0.05 were considered statistically significant. Results are presented as mean ± SD. *
indicates p<0.05; ** indicates p<0.01.
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Results
Reduced Cdc42 activity and adhesion defect in Fanca−/− and Fancc−/− MSC
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The bone marrow (BM) niche represents the supportive environment for hematopoietic stem
cells (HSCs) [34, 35]. As a major component of BM niche, mesenchymal stroma cells
(MSCs) being precursors to osteoblasts, adipocytes and chrondrocytes, are crucial for
maintenance of quiescent HSC [35]. To investigate the effect of FA deficiency on MSCs, we
first measured in vitro proliferating capacity of MSCs from mice deficient for the Fanca and
Fancc genes, which encode two essential components of the FA core complex (1–5). By
using a well-established MSC colony forming efficiency (CFE) assay [36], we observed a
significantly lower rate of proliferation of FA MSCs compared to that of wild-type (WT)
MSCs (Fig 1A). In addition, MSCs from Fanca−/− or Fancc−/− mice were more prone to
undergo senescence after four times passaging in culture as detected by SA-β-gal staining
(Fig 1B).
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The Rho GTPase, Cdc42 plays a critical role in mediating morphologic polarity in many cell
types and in regulating HSC differentiation [23, 24]. Hematopoietic stem and progenitor
cells (HSPCs) from FA patients and Fanca−/− mice have been shown to be defective in cell
adhesion and BM homing, and these defects are attributable, at least in part, to a reduced
Cdc42 GTPase activity that is subjected to FANCA regulation [25; unpublished data]. Given
the role of MSCs in regulating HSC function, we attempted to determine Cdc42 activity in
FA MSCs. We expanded the MSCs at passage 3 with a characteristic MSC surface
phenotype: CD45−CD11b−CD29+CD44+CD73+SCA-1+CD105+CD106+ (29; Fig S1A). The
MSCs also showed negligible levels of the Fanca or Fancc mRNA, thus confirming the
knockout genotypes of the cells (Fig S1B). Consistent with the decreased Cdc42 activity
observed in FA HSPCs [23], the active form of Cdc42-GTP in Fanca−/− and Fancc−/− MSCs
was reduced by more than 50% compared to that in WT MSCs (Fig 1C). Notably, Rac1GTP content of the Fanca−/− and Fancc−/− MSCs showed comparable level to that of WT
cells (Fig S1C).

Author Manuscript

It is known that nestin-expressing MSCs constitute an essential HSC niche component [3].
One of the most important features of MSC is hematopoiesis-supportive function. We then
asked whether the decreased Cdc42 activity in FA MSCs affected the adhesion of HSC to
MSCs. To this end, we performed a cell-cell adhesion assay by adding 5×105 BM cells
isolated from WT mice onto confluent MSC monolayers [19, 25]. After 4 hours of coculture, adherent cells were subjected to colony-forming cell (CFC) assay. The results
showed that adhesion of WT BM progenitor cells to Fanca−/− or Fancc−/− MSCs was
reduced by approximately 50% compared to those to WT MSCs (Fig 1D). These results
indicate a potential link between impaired adhesion of co-cultured WT progenitors and
decreased Cdc42 activity in FA MSCs.
Compromised hematopoietic supportive capacity of FA MSCs
To further characterize the hematopoiesis-supportive function of FA MSCs, we established
an ex vivo co-culture assay to examine the supportive capacity of Fanca−/− or Fancc−/−
MSCs on WT HSPCs. Limiting-dilution cobblestone area-forming cell (CAFC) assay [19,

Stem Cells. Author manuscript; available in PMC 2019 May 01.

Xu et al.

Page 7

Author Manuscript

32] (Fig S2) with graded numbers of flow sorted WT LSK cells showed that the frequencies
of CAFC, at both week 1 and week 2, was significantly reduced in co-cultures on Fanca−/−
or Fancc−/− MSCs compared to those on WT MSCs (Fig 2A), indicating that co-culture with
Fanca−/− and Fancc−/− MSCs compromises self-renewal capacity of WT HSPCs.
We next evaluate the repopulating ability of the co-cultured HSPCs in vivo by competitive
repopulation assay using 1×105 output cells that had been co-cultured for one week on WT,
Fanca−/− or Fancc−/− MSCs, along with 3×105 fresh BM competitor cells into lethally
irradiated BoyJ recipients. At 16 weeks post-transplantation, the frequency of donor-derived
cells, presumably the progenies of the output HSPCs, in the peripheral blood (PB) of mice
that injected with cells co-cultured on Fanca−/− or Fancc−/− MSCs was significantly lower
compared to that in the recipient mice that transplanted with cells co-cultured on WT MSCs
(Fig 2B), suggesting a defective hematopoiesis-supportive capacity of FA MSCs.
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To substantiate these findings, we next performed secondary transplantation by injecting
whole bone marrow cells (WBMCs) from primary recipients to sublethally irradiated BoyJ
recipients. Flow cytometry analysis at 16 weeks post BM transplantation (BMT) confirmed a
decrease in donor-derived chimera in the secondary recipient mice transplanted with
WBMCs from the primary recipients of co-cultured cells on Fanca−/− or Fancc−/− MSCs
(Fig 2C). In addition, we observed a significantly decreased proportion of progenitor cells
(Lin−Sca1+c-kit+, LSK) and phenotypic HSCs (LSKCD150+CD48−, SLAM; 37) in the
donor-derived compartment of these secondary recipient mice compared to those receiving
co-cultured cells on WT MSCs (Fig 2D). Together, these results indicate that FA MSCs are
defective in supporting long-term repopulation of co-cultured HSPCs.

Author Manuscript

Genetic correction of FA deficiency restores Cdc42 activity and hematopoietic supportive
capacity of FA MSCs

Author Manuscript

Since genetic correction of Fanca and Fancc deficiency can rescue FA HSPC function [38–
40], we asked whether complementation of FA deficiency could correct the hematopoietic
supportive defect of FA MSCs. To this end, we transduced MSCs isolated from Fanca−/− or
Fancc−/− mice as well as their WT littermates with retroviral vectors expressing eGFP,
eGFP-FANCA, or eGFP-FANCC. Sorted GFP+ cells (Fig S3) were then subjected to in vitro
co-culture experiments. Significantly, we noticed that FA gene correction restored Cdc42
activity to nearly the level observed in WT MSCs (Fig 3A) and reversed the senescent
phenotype of FA MSCs (Fig S4A). Concomitantly, complementation of Fanca−/− or Fancc
−/− MSCs with FANCA or FANCC almost completely rescued self-renewal defects of the
co-cultured WT HSC as determined by in vitro CFAC assay (Fig 3B). In addition, the output
progenies from the co-culture on the gene-corrected Fanca−/− or Fancc−/− MSCs exhibited
significantly improved hematopoietic reconstitution in both primary transplanted recipients
(Fig 3C) and secondary recipients (Fig 3D), as compared to those co-cultured on the vectoralone (eGFP)-transduced Fanca−/− or Fancc−/− MSCs. These data suggest that the
compromised supportive capacity of FA MSC is, at least in part, attribute to the decreased
Cdc42 activity.
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Since we observed reduced Cdc42 activity in FA MSCs, we next asked whether genetically
increased Cdc42 activation could improve the hematopoiesis-supportive function of Fanca−/−
and Fancc−/− MSCs. We took the approach of ectopically expressing the constitutively active
form of Cdc42 mutant (Cdc42F28L in Fanca−/− or Fancc−/− MSCs) by retroviral gene
transfer (Fig 4A). We found that forced expression of the constitutively active Cdc42F28L
reversed the senescent phenotype (Fig S4B) and significantly increased the frequency of
CAFC generated by WT HSPCs co-cultured on the transduced FA MSCs both at week 1 and
week 2 (Fig 4B). When transplanted into irradiated mice, donor hematopoietic repopulation
was profoundly increased in both primary and secondary recipients transplanted with the
progenies of the HSPCs co-cultured on Cdc42F28L-expressing Fanca−/− or Fancc−/− MSCs
(Fig 4C). Furthermore, analysis of secondary transplant recipients showed that ectopic
expression of the active Cdc42F28L significantly increased the numbers of donor-derived
progenitors (LSK) and HSCs (SLAM) (Fig 4D). These data further support the link of
Cdc42 activity of FA MSCs to their hematopoiesis-supportive function.
Wnt5a improves FA MSCs function in supporting hematopoiesis of WT co-cultures
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Recent studies have shown that stem-cell-intrinsic elevation of non-canonical Wnt5a plays a
causative role in Cdc42 activation and HSC ageing [31]. We next asked whether Wnt5a
could improve FA MSC function. Treatment of Fanca−/− or Fancc−/− MSCs with Wnt5a
restored the active form of Cdc42 (Cdc42-GTP) to the normal WT level (Fig 5A) and
reversed the senescent phenotype (Fig S4C). Pre-treatment Fanca−/− or Fancc−/− MSCs with
Wnt5a also significantly increased cobblestone formation of the co-cultured WT HSPCs
(Fig 5B). Furthermore, we observed a significant increase of donor-derived chimera in both
primary and secondary recipient mice transplanted with the progenies cultured on Fanca−/−
or Fancc−/− MSCs pre-treated with Wnt5a (Fig 5C). Finally, analysis of showed that Wnt5a
there was a significant increase in the numbers of donor-derived LSK and SLAM cells in the
secondary transplant recipients of the progenies cultured on Fanca−/− or Fancc−/− MSCs pretreated with Wnt5a (Fig 5D). Thus, non-canonical Wnt5a improves FA MSC function
through restoring Cdc42 activity.
FA proteins regulate Cdc42 activity via modulating Wnt5a expression
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We next attempted to investigate the potential mechanism by which the FA pathway
regulates Cdc42 activity. To this end, we transduced WT, Fanca−/−, Fancc−/− MSCs with
retroviral vectors expressing eGFP, eGFP-FANCA, or eGFP-FANCC. Sorted GFP+ cells
(Fig S3) were then subjected to analysis for the expression of Wnt5a. Significantly, we
noticed that both mRNA and protein levels of Wnt5a were profoundly lower in Fanca−/− and
Fancc−/− MSCs than those in their WT counterparts (Fig 6A). Gene correction of FA
deficiency significantly increased the levels of Wnt5a mRNA and protein (Fig 6A).
Consistently, pretreatment of Wnt5a restored Wnt5a expression in FA MSCs to almost the
levels seen in WT cells (Fig 6B). These results suggest that FA proteins play an important
role in regulating Cdc42 activity at least in part through modulating Wnt5a expression.
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Discussion
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HSCs reside in the BM microenvironment (niche) where they preserve the capacity to selfrenew and to continue producing all types of blood lineages throughout a prolonged lifespan
[12]. The niche is composed mostly by MSCs, endothelial cells and additional factors [17,
42]. The molecular crosstalk between HSCs and the cellular constituents of these niches
controls the balance between HSC self-renewal and differentiation [42]. Thus, defining
niche components and how they work in concert to regulate hematopoiesis will provide the
opportunity to improve the regeneration of HSCs, and reveal potential therapies for patients
with BM failure and leukemia as well as other hematologic diseases. In this study, we
demonstrated a deficit hematopoiesis-supportive function of FA MSCs and identified Cdc42
as a critical niche component in regulating this supportive function of FA MSCs. We have
provided several lines of evidence to support our conclusion: (1) MSCs deficient for the
Fanca or Fancc gene are defective in proliferating and prone to undergo senescence. (2)
Cdc42 activity is significantly decreased in Fanca−/− and Fancc−/− MSCs. (3) WT HSPCs
co-cultured on Fanca−/− or Fancc−/− MSCs exhibit compromised proliferating capacity both
in vitro and in vivo. (4) Genetically correction of FA deficiency restores Cdc42 activity in
FA MSCs. (5) Ectopic expression of a constitutively activating form of Cdc42 rescues
hematopoiesis-supportive defects of FA MSCs. (6) Activation of Cdc42 by Wnt5a improves
the hematopoiesis-supportive function of FA MSCs.

Author Manuscript

FA is a genomic instability syndrome associated with progressive BM failure and cancer
susceptibility [6]. Common to all subtypes is cellular sensitivity to endogenously or
exogenously produced interstrand cross links (ICLs), implicating spontaneous and induced
chromosomal breakage, cell-cycle arrest and reduced cell survival [43, 44]. Consistent with
these cellular phenotypes, we found that MSCs deficient for Fanca or Fancc gene are
defective in proliferating when cultured in vitro by colony forming efficiency (CFE) assay
(Fig 1A). In addition, compared with WT MSCs, FA MSCs tend to undergo senescence at
earlier passages in culture (Fig 1B). These results are in line with the previous studies that
show that FA MSCs are defective in their ability to survive in vitro and display spontaneous
chromosome breakages [45].

Author Manuscript

Cdc42 is a member of Rho GTPase family. Previous studies have shown that conditional
knockout of Cdc42 in murine HSCs led to defective F-actin polymerizarion, reduced
adhesion to fibronectin matrix or stroma cells, dampened directional migration in response
to SDF1α, and a massive egress of HSPCs from BM to PB, liver and spleen [23]. In the
context of FA, a recent study used primary BM samples from FA patients and patientderived FA lymphoblast cell lines to demonstrate that the human FA hematopoietic cells
have an intrinsic decrease in the activity of Cdc42 [25]. Another recent study shows that
Cdc42 is a cell polarity determinant and controls cell division symmetry to block leukemia
cell differentiation [46]. Our unpublished data indicate that FA murine HPSCs also exhibit
lower Cdc42 activity compared to the WT counterparts and that Cdc42 is de-polarized in FA
HSCs (unpublished data). In this study, we show that MSCs from mice deficient for Fanca or
Fancc have a reduced Cdc42 activity compared to WT MSCs (Fig 1C). Interestingly, FA
deficiency does not affect Rac1-GTP content of Fanca−/− and Fancc−/− MSCs (Fig S1B),
suggesting that the defect may be Cdc42-specific. Although it is currently not clear how
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Cdc42 activity is regulated in FA cells, our findings that genetic correction of FA deficiency
(Fig 3), ectopic expression of a constitutively activating form of Cdc42 (Fig 4), or treatment
with the non-canonical Wnt5a (Fig 5) can restore Cdc42 activity in FA MSCs shed some
light on understanding the underlying regulatory mechanism of Cdc42 activity.
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It has been shown that FA proteins interact with CtBP1 (the transcriptional corepressor
protein C-terminal binding protein-1) and modulate the expression of the Wnt antagonist
Dickkopf-1 (DKK1) [41]. Knocking down FANCD2 in Hela cells significantly upregulates
DKK1 expression. It is also known that Rho GTPases integrate Wnt-induced signals
spatially and temporally to promote morphological and transcriptional changes affecting cell
behavior [47]. Specifically, Cdc42 and non-canonical Wnt signal transduction pathways
coordinate to promote cell polarity [48]. Recent study demonstrated that Wnt5a activates
Cdc42 to induce an ageing-like phenotype in young HSCs [31]. Our qPCR and ELISA
analysis show that both mRNA and protein levels of Wnt5a are significantly lower in MSCs
deficient for the Fanca or Fancc gene (Fig 6). Gene correction of FA deficiency (Fig 6A) or
pretreatment of Wnt5a (Fig 6B) restores both mRNA and protein levels of Wnt5a in Fanca
−/− and Fancc−/− MSCs. Our studies, taken together with the other referenced reports,
suggest that FA proteins regulate Cdc42 activity possibly via modulating Wnt5a expression.
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Another intriguing finding of the present study is our observation that loss of FA deficiency
compromises the hematopoiesis-supportive function of MSCs. The hematopoietic supportive
function is one of the important features of BM MSCs. It has been well established that the
stromal feeder layer can be used to support HSC expansion and maintain stem cell
quiescence both in vivo and in vitro [12, 42, 49]. It is also speculated that the environment
beneath and/or niche atmosphere created by healthy MSC layer are critical for maintaining
HSCs in an immature state [49]. Recent studies on the cellular characteristics of MSCs
derived from the BM of certain FA patients implicate a role of the BM niche in the
pathophysiology of FA BM failure [18–20]. In addition, a recent study using primary BM
samples from FA patients and patient-derived FA lymphoblast cell lines demonstrates that
the cell-autonomous defects of FA HSPCs in BM homing and engraftment are associated
with a decrease in the activity of Cdc42 [25]. More recently, a study using Fancc and Fancg
double knockout mouse model describes a phenotypic hematopoiesis-supportive defects of
MSCs [50]. Our studies, taken together with these reports, suggest that FA gene deficiency
compromises the function of MSC in supporting hematopoiesis, which is, at least in part,
responsible for the hematopoietic defects observed in FA. Our study goes further to link this
compromised hematopoiesis- supporting function to decreased Cdc42 activity in FA MSCs.
In this context, our results suggest that targeted manipulation of Cdc42 activity in MSCs
could be a therapeutic strategy to improve hematopoiesis and stem cell transplantation for
FA patients.
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Fig. 1. Reduced Cdc42 activity and adhesion defect in Fanca−/− and Fancc−/− MSCs
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(A) Fanca−/− and Fancc−/− MSCs exhibit defective proliferation in vitro. MSCs isolated from
wild-type (WT), Fanca−/− or Fancc−/− mice were cultured in MSC medium followed by
MSC colony forming efficiency (CFE) assay. Numbers of colonies formed were enumerated
on day 12 in triplicate from five individual WT, Fanca−/− or Fancc−/− mice. Quantification
are shown. (B) Fanca−/− and Fancc−/− MSCs are prone to senescence. Cells described in (A)
were passaged for 3 times in vitro followed by SA-β-gal staining. Percentages of the cells
stained positive for SA-β-gal were quantified by counting a total of 100 cells in random
fields per well. (C) Decreased Cdc42 activity in Fanca−/− and Fancc−/− MSCs. MSCs
isolated from WT, Fanca−/− or Fancc−/− mice were cultured in MSC medium and passaged
for 3 times. Whole cell lysates (WCL) was then extracted from the cells and subjected to
Western blotting using antibodies against Cdc42. The level of active, GTP-bound Cdc42,
total Cdc42 and β-actin were determined. The relative levels of active Cdc42 are indicated
below the blot. (D) WT HSPCs co-cultured on Fanca−/− or Fancc−/− MSCs display
decreased adhesion. Sorted LSK (Lin−Sca1+c-kit+) cells from WT mice were added onto
confluent WT, Fanca−/− or Fancc−/− BM-derived MSCs and incubated for 4 hours at 37°C;
non-adherent cells were then subjected to colony forming cell (CFC) assay. Numbers are
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given as the percentage of input CFCs with three independent experiments in triplicates in
each experiments (n=5). *p<0.05.
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Fig. 2. Compromised hematopoietic supportive capacity of FA MSCs
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(A) Co-cultured WT HSCs exhibit reduced Cobblestone area-forming capacity (CAFC).
Sorted LSK (Lin−Sca1+c-kit+) cells from WT mice were added onto confluent WT, Fanca−/−
or Fancc−/− BM-derived MSCs and incubated for 4 hours at 37°C followed by Limited
dilution analysis (LDA) of CAFC. Assay was conducted in a flat bottom 96 well plate with
confluent MSCs before plating the sorted LSK cells. Cultures were maintained in 40%
methylcellulose medium for two weeks and colonies were counted on week 1 and 2. Group
of at least 6 phase dim cells were counted as one colony. (B) Reduced in vivo repopulating
capacity of WT HSPCs co-cultured with FA MSCs. Co-cultured WT LSK cells were
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transplanted into lethally irradiated BoyJ recipients. Donor-derived chimera were determined
at 4 and 16 weeks post-transplant. (C, D) FA MSCs fail to support long-term hematopoiesis.
Whole bone marrow cells (WBMCs) isolated from recipients described in (B) at 16 weeks
post-transplant were transplanted into sublethally irradiated BoyJ recipients. Donor-derived
chimera (Total CD45.2+; C) and percentages of LSK, SLAM cells in the donor-derived
(Total CD45.2+) cell compartment (D) were determined at 16-weeks post-transplant.
Representative flow plots and quantifications were shown. Results are means ± standard
deviation (SD) of 3 independent experiments (n=9 per group). *p<0.05; ** p<0.01.
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Fig. 3. Genetic correction of FA deficiency restores Cdc42 activity and supportive function of FA
MSC
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(A) Genetic correction of FA deficiency restores Cdc42 activity in FA MSCs. MSCs isolated
from WT, Fanca−/− or Fancc−/− mice were transduced with retroviral vector expressing
eGFP, eGFP-FANCA, or eGFP-FANCC. Sorted GFP+ cells were subjected to in vitro Cdc42
pull down assay. The level of active, GTP-bound Cdc42, total Cdc42 and β-actin were
determined. (B) Complementation of FANCA or FANCC improves CFAC of FA MSCs.
Sorted GFP+ MSC cells described in (A) were co-cultured with graded numbers of flow
sorted WT LSKs. Cultures were maintained in 40% methyl cellulose medium for two weeks
and the colonies were counted on week 1 and 2. Group of at least 6 phase dim cells were
counted as one colony. (C) Genetic correction of FA deficiency improves reconstitution of
co-cultured WT HSCs in irradiated recipients. Co-cultured WT LSK cells described in (B)
were transplanted into lethally irradiated BoyJ recipients. Donor-derived chimera was
detected by flow cytometry analysis at 4 and 16 weeks post-transplant. (D)
Complementation of FA deficiency improves long-term repopulating capacity of co-culture
cells. WBMCs from the primary recipients were transplanted into sublethally irradiated
BoyJ recipients. Donor-derived chimera were determined 16 week post transplant.
Representative flow plots and quantifications were shown. Results are means ± standard
deviation (SD) of 3 independent experiments (n=9 per group). *p<0.05; ** p<0.01.
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Fig. 4. Expression of the constitutively active Cdc42 improves hematopoietic supportive function
of FA MSCs
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(A) Ectopic expression of Cdc42F28L in FA MSCs. MSCs isolated from WT, Fanca−/− or
Fancc−/− mice were transduced with retroviral vector expressing the constitutively active
Cdc42 mutant, Cdc42F28L. Sorted GFP+ MSC cells were subjected to Western blot
analysis. Expression of the constitutive active mutant of Cdc42 (Cdc42-F28L) containing an
N-terminal HA tag in WT, Fanca−/− or Fancc−/− MSCs was analyzed by anti-HA western
blotting. (B) Expression of Cdc42F28L improves Cobblestone forming of co-cultured WT
HSPCs. Sorted GFP+ MSC cells described in (A) were co-cultured with graded numbers of
flow sorted WT LSKs. Scoring of Cobblestone area as endpoint was determined after 7
days. (C) Expression of the constitutive active Cdc42 in FA MSCs improves repopulating
ability of co-cultured WT HSPCs in vivo. Co-cultured WT HSPCs described in (B) along
with 3×105 congenic BM cells isolated from BoyJ mice were transplanted into lethally
irradiated BoyJ recipients. Donor-derived chimera were analyzed at the indicated time
points. (D) Ectopic expression of Cdc42F28L improves long-term repopulating of co-culture
WT HSPCs in the recipients. Secondary BMT was performed by injecting WBMCs from
recipients described in (C) at 16 weeks post transplant. Donor-derived chimera, LSK and
SLAM cells were analyzed at 16 weeks post transplant. *p<0.05; ** p<0.01.
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Fig. 5. Activation of Cdc42 by Wnt5a improves hematopoietic supportive function of FA MSCs

Author Manuscript

(A) Wnt5a activates Cdc42 in FA MSCs. MSCs isolated from WT, Fanca−/− or Fancc−/−
mice were treated with Wnt5a followed by Western blot analysis using antibodies against
Cdc42. The level of active, GTP-bound Cdc42, total Cdc42 and β-actin were determined.
The relative levels of active Cdc42 are indicated below the blot. (B) Wnt5a treatment
improves Cobblestone forming of co-cultured WT HSPCs. MSCs described in (A) were cocultured with graded numbers of flow sorted WT LSKs. Scoring of Cobblestone area as
endpoint was determined after 7 days. Results are means ± standard deviation (SD) of 3
independent experiments (n=6 per group). (C) Pretreatment of FA MSCs with Wnt5a
improves reconstituting hematopoiesis of co-cultured WT HSPC in irradiated recipient. Cocultured WT HSPCs described in (B) along with 3×105 congenic BM cells isolated from
BoyJ mice were transplanted into lethally irradiated BoyJ recipients. Donor-derived chimera
were analyzed at the indicated time points. (D) Wnt5a treatment improves long-term
repopulating of co-cultured WT HSPCs in secondary recipients. Secondary BM transplant
was performed by injecting WBMCs from the primary recipients described in (C). Donorderived chimera, LSK and SLAM cells were analyzed at 16 weeks post-secondary
transplant. Representative flow plots and quantifications were shown. Results are means ±
standard deviation (SD) of 3 independent experiments (n=9 per group). *p<0.05; ** p<0.01.
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Fig. 6. FA proteins regulate Cdc42 activity via modulating Wnt5a expression
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(A) FA gene correction rescues Wnt5a mRNA and protein expression. MSCs from WT,
Fanca−/− or Fancc−/− mice were transduced with retroviral vector expressing eGFP, eGFPFANCA, or eGFP-FANCC. Sorted GFP+ cells were subjected to RNA extraction and qPCR
analysis using the primers listed in Table S1 or ELISA assay. Samples were normalized to
the level of GAPDH mRNA. (B) Wnt5a treatment upregulates Wnt5a mRNA and protein
expression. MSCs isolated from WT, Fanca−/− or Fancc−/− mice were treated with Wnt5a
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followed by qPCR analysis for Wnt5a mRNA (Left) and ELISA analysis for Wnt5a protein
(Right). *p<0.05; ** p<0.01.
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